weight loss drugs non glp 1 A new UGA-led meta-analysis compared the three FDA-approved GLP-1 medications used for in non-diabetic patients. Researchers found that tirzepatide was associated with the greatest weight reduction, with participants losing more The Boom in New Weight

Glucagon-like peptide-1 receptor regulation of basal dopamine transporter activity is species-dependent

18 With continued efforts in the development of newer antidiabetic agents, unimolecular GLP1R/GIPR dual agonists (twincretins) can provide added efficacy, especially among obese individuals with T2DM

(e.g., RTW, Atlas, Bain Capital Life Sciences) Biotech VCs determine what GLP-1 era 2.0 looks like, and founders should watch them closely because they create long-term infrastructure needs

doi:10.1371/journal.pone.0009590 38

In contrast, both semaglutide and tirzepatide treated groups showed a significant reduction in liver fibrosis compared to their respective diet-restricted controls

The most significant is a boxed warning from the FDA about a potential risk of thyroid tumors, including a rare type of thyroid cancer called medullary thyroid carcinoma (MTC)